This includes confirming the regulation of STAT3 by Sestrins across various tumour contexts, defining the transcriptional interplay between Sestrins and Nrf2 in oncogenic settings, and clarifying the mechanisms by which Sestrins interact with mTORC2 and activate AKT signalling in cancer. This evidence concerns the gene AKT1 and cancer.